Michigan State University / Breslin Cancer Center Breslin Cancer Center (3) — Lansing, Michigan

Michigan State University / Breslin Cancer Center Breslin Cancer Center (3) is a clinical research site located in Lansing, Michigan, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Michigan State University / Breslin Cancer Center Breslin Cancer Center (3) has participated in 1 clinical trials.

Therapeutic areas: CML.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Michigan State University / Breslin Cancer Center Breslin Cancer Center (3)?

Michigan State University / Breslin Cancer Center Breslin Cancer Center (3) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Michigan State University / Breslin Cancer Center Breslin Cancer Center (3) conducted?

Michigan State University / Breslin Cancer Center Breslin Cancer Center (3) has 1 clinical trials on record. Their work covers CML.

Is Michigan State University / Breslin Cancer Center Breslin Cancer Center (3) accredited by Crixeo Health?

Michigan State University / Breslin Cancer Center Breslin Cancer Center (3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Michigan State University / Breslin Cancer Center Breslin Cancer Center (3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.